Cheng · The AAPS journal 2019 · In vitro laboratory experiment · n=?

Moringa Isothiocyanate Activates Nrf2: Potential Role in Diabetic Nephropathy.

Cited 72 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro bench study using cell culture models with no human subjects.

PubMed 30783799 · doi:10.1208/s12248-019-0301-6 · record verified 2026-08-30

What was done

Researchers evaluated the antioxidant and anti-inflammatory mechanisms of moringa isothiocyanate (MIC-1) from Moringa oleifera compared to sulforaphane (SFN). In cell culture models, they assessed MIC-1 cytotoxicity (1.25–5 μM), Nrf2-ARE activation, downstream gene and protein expression (NQO1, HO-1, GCLC), and cytokine suppression in lipopolysaccharide (LPS)-stimulated macrophages. In human renal proximal tubule (HK-2) cells exposed to high glucose, they measured reactive oxygen species (ROS) and performed RNA-sequencing with Ingenuity Pathway Analysis to analyze transcriptomic changes with and without MIC-1 treatment.

What was found

MIC-1 exhibited minimal toxicity at 1.25–5 μM and activated Nrf2-ARE at levels comparable to SFN. MIC-1 increased gene and protein expression of downstream Nrf2 targets (NQO1, HO-1, and GCLC) and suppressed pro-inflammatory cytokines in LPS-stimulated macrophages. In high-glucose-treated HK-2 cells, MIC-1 reduced ROS levels and reversed high-glucose-induced gene expression alterations in the TGFβ1 and NQO1 pathways. No numerical effect sizes or confidence intervals were reported in the abstract.

Why it matters

This study demonstrates that moringa isothiocyanate functions as an Nrf2 activator with antioxidant and anti-inflammatory properties in renal cells exposed to high glucose. It provides a preclinical mechanistic rationale for exploring MIC-1 in models of diabetic nephropathy.

Limits

This is entirely an in vitro study conducted in cultured cell lines (macrophages and HK-2 tubule cells), which cannot account for in vivo bioavailability, pharmacokinetics, tissue distribution, or complex systemic disease pathology. Quantitative values and statistical variance metrics were omitted from the abstract, and no animal or human clinical data were collected.

Cited by